Deccan Healthcar

{
  "main_header": {
    "sid": 1003095,
    "name": "Deccan Healthcar",
    "stock_name": "Deccan Healthcar",
    "full_name": "Deccan Health Care Ltd",
    "name_url": "stocks-analysis/deccan-healthcar",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "12.93",
    "chg": -0.06,
    "chgp": "-0.46%",
    "dir": -1,
    "prev_price": "12.99",
    "mcapval": "32.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 542248,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 4,
    "sector_id": 35,
    "indexname": "India SENSEX",
    "isin": "INE452W01019",
    "curr_date": "Jul 17, 03:30 PM",
    "curr_time": "03:05 AM",
    "last_traded_at": "Jul 17, 03:30 PM IST",
    "bse_nse_vol": 727,
    "exc_status": "Active",
    "traded_date": "Jul 17, 2026",
    "traded_date_str": "2026 07 17",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/deccan-healthcar-1003095-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Deccan Health Care Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/deccan-health-care-ltd-is-rated-sell-4093403",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/DeccanHealthCar_mojoScore_4093403.png",
        "date": "2026-07-08 10:10:56",
        "description": "Deccan Health Care Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 July 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Deccan Health Care Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/deccan-health-care-ltd-is-rated-sell-4062997",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/DeccanHealthCar_mojoScore_4062997.png",
        "date": "2026-06-19 10:11:29",
        "description": "Deccan Health Care Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 June 2026, providing investors with the most up-to-date insight into the company’s performance and outlook."
      },
      {
        "title": "Deccan Health Care Declines 2.72%: Valuation Shift Amid Mixed Weekly Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/deccan-health-care-declines-272-valuation-shift-amid-mixed-weekly-performance-4051906",
        "imagepath": "",
        "date": "2026-06-13 16:03:20",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>1 June:</strong> Q4 FY26 results reveal plunging profitability despite revenue growth</p>\n                    <p><strong>3 June:</strong> Valuation upgraded to very attractive amid challenging returns</p>\n                    <p><strong>5 June:</strong> Week closes at Rs.12.50, down 2.72% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.12.85</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.12.50</div><div class=\"stat-change negative\">-2.72%</div></div>\n                  ..."
      },
      {
        "title": "Deccan Health Care Ltd Valuation Shifts to Very Attractive Amidst Challenging Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/deccan-health-care-ltd-valuation-shifts-to-very-attractive-amidst-challenging-returns-4032801",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/DeccanHealthCar_valuationdot_4032801.png",
        "date": "2026-06-03 08:02:04",
        "description": "Deccan Health Care Ltd has witnessed a significant shift in its valuation parameters, moving from an attractive to a very attractive price range, driven by a marked decline in its price-to-earnings and price-to-book value ratios. This repositioning comes amid a challenging market backdrop and a micro-cap status that continues to weigh on investor sentiment despite recent positive price movements."
      },
      {
        "title": "Are Deccan Health Care Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-deccan-health-care-ltd-latest-results-good-or-bad-4028141",
        "imagepath": "",
        "date": "2026-06-01 19:29:41",
        "description": "Deccan Health Care Ltd's latest financial results for Q4 FY26 reveal a complex operational landscape characterized by notable revenue growth juxtaposed against significant profitability challenges. The company reported a net sales figure of ₹20.98 crores, reflecting a quarter-on-quarter growth of 20.64%, which is a positive development compared to the previous quarter's decline. However, this revenue increase did not translate into improved profitability, as net profit fell sharply by 67.00% to ₹0.33 crores from ₹1.00 crore in Q3 FY26.\n\nThe operating margin also contracted considerably, dropping from 9.95% in Q3 to 4.24% in Q4, indicating operational difficulties that may stem from either cost pressures or aggressive pricing strategies aimed at driving sales volume. Similarly, the PAT margin experienced a decline from 5.75% to 1.57%, further underscoring the strain on profitability despite the uptick in rev..."
      },
      {
        "title": "Deccan Health Care Q4 FY26: Profitability Plunges Despite Revenue Growth",
        "link": "https://www.marketsmojo.com/news/result-analysis/deccan-health-care-q4-fy26-profitability-plunges-despite-revenue-growth-4026781",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/DeccanHealthCar_quaterlyResult_4026781.png",
        "date": "2026-06-01 12:25:42",
        "description": "Deccan Health Care Limited, a micro-cap healthcare products company specialising in nutraceutical, cosmeceutical and ayurveda products, reported a challenging Q4 FY26 with net profit declining 67.00% quarter-on-quarter to ₹0.33 crores despite revenue growing 20.64% to ₹20.98 crores. The ₹32.00 crore market capitalisation company saw its stock trade at ₹12.80, down 43.36% over the past year and significantly underperforming both the Sensex and its healthcare services sector peers."
      },
      {
        "title": "Deccan Health Care Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/deccan-health-care-ltd-upgraded-to-sell-on-technical-improvements-despite-weak-fundamentals-3998402",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DeccanHealthCar_mojoScore_3998402.png",
        "date": "2026-05-19 08:56:38",
        "description": "Deccan Health Care Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 18 May 2026, driven primarily by a shift in technical indicators despite persistent fundamental challenges. The healthcare services micro-cap, with a current market price of ₹12.33, continues to underperform the broader market but shows signs of stabilisation in its technical trend, prompting a reassessment of its outlook."
      },
      {
        "title": "Deccan Health Care Ltd Downgraded to Strong Sell Amid Technical Weakness and Long-Term Underperformance",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/deccan-health-care-ltd-downgraded-to-strong-sell-amid-technical-weakness-and-long-term-underperformance-3988915",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DeccanHealthCar_mojoScore_3988915.png",
        "date": "2026-05-13 08:37:35",
        "description": "Deccan Health Care Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 12 May 2026, reflecting deteriorating technical indicators and persistent fundamental weaknesses. Despite some positive quarterly financial results and rising promoter confidence, the stock’s overall outlook has worsened due to bearish technical trends, underwhelming long-term returns, and valuation concerns within the healthcare services sector."
      },
      {
        "title": "Deccan Health Care Ltd Upgraded to Sell on Technical Improvements and Valuation Appeal",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/deccan-health-care-ltd-upgraded-to-sell-on-technical-improvements-and-valuation-appeal-3969599",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/DeccanHealthCar_mojoScore_3969599.png",
        "date": "2026-04-30 08:16:50",
        "description": "Deccan Health Care Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 29 Apr 2026, driven primarily by a shift in technical indicators despite persistent fundamental challenges. The healthcare services micro-cap, with a market capitalisation classified as micro-cap and a current Mojo Score of 34.0, has demonstrated mixed signals across quality, valuation, financial trends, and technical parameters, prompting a nuanced reassessment by analysts."
      }
    ],
    "total": 175,
    "sid": "1003095",
    "stock_news_url": "https://www.marketsmojo.com/news/deccan-health-care-1003095"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "11-Jul-2026",
      "details": "Intimation",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "03-Jul-2026",
      "details": "Newspaper Publication for Notice of EGM & E-Voting Information.",
      "source": "BSE"
    },
    {
      "caption": "Notice Of The Extra-Ordinary General Meeting (EGM) Scheduled To Be Held On Friday 24Th July 2026 At 03:00 P.M IST Through Video Conferencing.",
      "datetime": "02-Jul-2026",
      "details": "Notice of EGM",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Deccan Health Care Ltd is Rated Sell

2026-07-08 10:10:56

Deccan Health Care Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 July 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Deccan Health Care Ltd is Rated Sell

2026-06-19 10:11:29

Deccan Health Care Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 June 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.

Read full news article

Deccan Health Care Declines 2.72%: Valuation Shift Amid Mixed Weekly Performance

2026-06-13 16:03:20

Key Events This Week

1 June: Q4 FY26 results reveal plunging profitability despite revenue growth

3 June: Valuation upgraded to very attractive amid challenging returns

5 June: Week closes at Rs.12.50, down 2.72% for the week

Week Open

Rs.12.85

Week Close

Rs.12.50

-2.72%

...

Read full news article

Deccan Health Care Ltd Valuation Shifts to Very Attractive Amidst Challenging Returns

2026-06-03 08:02:04

Deccan Health Care Ltd has witnessed a significant shift in its valuation parameters, moving from an attractive to a very attractive price range, driven by a marked decline in its price-to-earnings and price-to-book value ratios. This repositioning comes amid a challenging market backdrop and a micro-cap status that continues to weigh on investor sentiment despite recent positive price movements.

Read full news article

Are Deccan Health Care Ltd latest results good or bad?

2026-06-01 19:29:41

Deccan Health Care Ltd's latest financial results for Q4 FY26 reveal a complex operational landscape characterized by notable revenue growth juxtaposed against significant profitability challenges. The company reported a net sales figure of ₹20.98 crores, reflecting a quarter-on-quarter growth of 20.64%, which is a positive development compared to the previous quarter's decline. However, this revenue increase did not translate into improved profitability, as net profit fell sharply by 67.00% to ₹0.33 crores from ₹1.00 crore in Q3 FY26. The operating margin also contracted considerably, dropping from 9.95% in Q3 to 4.24% in Q4, indicating operational difficulties that may stem from either cost pressures or aggressive pricing strategies aimed at driving sales volume. Similarly, the PAT margin experienced a decline from 5.75% to 1.57%, further underscoring the strain on profitability despite the uptick in rev...

Read full news article

Deccan Health Care Q4 FY26: Profitability Plunges Despite Revenue Growth

2026-06-01 12:25:42

Deccan Health Care Limited, a micro-cap healthcare products company specialising in nutraceutical, cosmeceutical and ayurveda products, reported a challenging Q4 FY26 with net profit declining 67.00% quarter-on-quarter to ₹0.33 crores despite revenue growing 20.64% to ₹20.98 crores. The ₹32.00 crore market capitalisation company saw its stock trade at ₹12.80, down 43.36% over the past year and significantly underperforming both the Sensex and its healthcare services sector peers.

Read full news article

Deccan Health Care Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals

2026-05-19 08:56:38

Deccan Health Care Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 18 May 2026, driven primarily by a shift in technical indicators despite persistent fundamental challenges. The healthcare services micro-cap, with a current market price of ₹12.33, continues to underperform the broader market but shows signs of stabilisation in its technical trend, prompting a reassessment of its outlook.

Read full news article

Deccan Health Care Ltd Downgraded to Strong Sell Amid Technical Weakness and Long-Term Underperformance

2026-05-13 08:37:35

Deccan Health Care Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 12 May 2026, reflecting deteriorating technical indicators and persistent fundamental weaknesses. Despite some positive quarterly financial results and rising promoter confidence, the stock’s overall outlook has worsened due to bearish technical trends, underwhelming long-term returns, and valuation concerns within the healthcare services sector.

Read full news article

Deccan Health Care Ltd Upgraded to Sell on Technical Improvements and Valuation Appeal

2026-04-30 08:16:50

Deccan Health Care Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 29 Apr 2026, driven primarily by a shift in technical indicators despite persistent fundamental challenges. The healthcare services micro-cap, with a market capitalisation classified as micro-cap and a current Mojo Score of 34.0, has demonstrated mixed signals across quality, valuation, financial trends, and technical parameters, prompting a nuanced reassessment by analysts.

Read full news article

View All News